Pharmacogenetics: Current status and future perspectives

Current Pharmaceutical Design

Volumn 16, Issue 2, 2010, Pages 135-

  Guchelaar, Henk Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MENADIONE EPOXIDE; PENTOSE PHOSPHATE; PRIMAQUINE; SUXAMETHONIUM;

DRUG RESPONSE; DRUG SAFETY; EDITORIAL; ERYTHROCYTE METABOLISM; FOOD AND DRUG ADMINISTRATION; GENETIC VARIABILITY; GENOMICS; HEMOLYTIC ANEMIA; MUSCLE RELAXATION; PHARMACOGENETICS; PRIORITY JOURNAL;

HUMAN GENOME PROJECT; HUMANS; PHARMACOGENETICS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77949479463     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161210790112692     Document Type: Editorial

References (6)

1. Garrod AE. The inborn errors of metabolism. London: Oxford University Press 1909; p. 168.
2. Weinshilboum R. Genomic medicine: inheritance and drug response. N Engl J Med 2003; 348: 529-37.
3. Kalow W. Pharmacogenetics and personalised medicine. Fund Clin Pharmacol 2002; 16: 337-42.
4. Swen JJ, Huizinga TW, Gelderblom H, de Vries EGE, Assendelft WJJ, Kirchheiner J, et al. Translating pharmacogenomics: challenges on the road to the clinic. Plos Med 2007; 4(8): e209
5. Swen JJ, Wilting I, de Goede AL, Grandia L, Mulder H, Touw DJ, et al. Pharmacogenetics: from bench to byte. Clin Pharmacol Ther 2008; 83(5): 781-7.
6. Kirchheiner J, Nickchen K, Bauer M, Wong ML, Licinio J, Roots I, et al. Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response. Mol Psychiatry 2004; 9(5): 442-73.